Blood circulating C228T TERT gene promoter mutation is an independent factor for the prognosis of HBV-related hepatocellular carcinoma.

Quang Trung P, Chau P, Quang Huy D, Xuan Hoan N, Reboud J, Linh Toan N, Huu Song L, Tat Trung N

Open source

DOI
10.1186/s12885-026-16271-0
Published
2026 Jun 3
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16271-0,
  title = {Blood circulating C228T TERT gene promoter mutation is an independent factor for the prognosis of HBV-related hepatocellular carcinoma.},
  author = {Quang Trung P and Chau P and Quang Huy D and Xuan Hoan N and Reboud J and Linh Toan N and Huu Song L and Tat Trung N},
  year = {2026},
  journal = {BMC cancer},
  doi = {10.1186/s12885-026-16271-0},
  url = {https://doi.org/10.1186/s12885-026-16271-0}
}

RIS

TY  - JOUR
TI  - Blood circulating C228T TERT gene promoter mutation is an independent factor for the prognosis of HBV-related hepatocellular carcinoma.
AU  - Quang Trung P
AU  - Chau P
AU  - Quang Huy D
AU  - Xuan Hoan N
AU  - Reboud J
AU  - Linh Toan N
AU  - Huu Song L
AU  - Tat Trung N
PY  - 2026
JO  - BMC cancer
DO  - 10.1186/s12885-026-16271-0
UR  - https://doi.org/10.1186/s12885-026-16271-0
ER  - 

APA

P, Q. T., P, C., D, Q. H., N, X. H., J, R., N, L. T., L, H. S., & N, T. T. (2026). Blood circulating C228T TERT gene promoter mutation is an independent factor for the prognosis of HBV-related hepatocellular carcinoma.. BMC cancer. https://doi.org/10.1186/s12885-026-16271-0

Source records